483 related articles for article (PubMed ID: 25355595)
21. Association of a missense single nucleotide polymorphism, Cys1367Arg of the WRN gene, with the risk of bone and soft tissue sarcomas in Japan.
Nakayama R; Sato Y; Masutani M; Ogino H; Nakatani F; Chuman H; Beppu Y; Morioka H; Yabe H; Hirose H; Sugimura H; Sakamoto H; Ohta T; Toyama Y; Yoshida T; Kawai A
Cancer Sci; 2008 Feb; 99(2):333-9. PubMed ID: 18271933
[TBL] [Abstract][Full Text] [Related]
22. Genetic variants in DNA repair genes as potential predictive markers for oxaliplatin chemotherapy in colorectal cancer.
Kap EJ; Seibold P; Richter S; Scherer D; Habermann N; Balavarca Y; Jansen L; Becker N; Pfütze K; Popanda O; Hoffmeister M; Ulrich A; Benner A; Ulrich CM; Burwinkel B; Brenner H; Chang-Claude J
Pharmacogenomics J; 2015 Dec; 15(6):505-12. PubMed ID: 25778469
[TBL] [Abstract][Full Text] [Related]
23. Functional Analysis of SNPs in the ERCC5 Promoter in Advanced Colorectal Cancer Patients Treated With Oxaliplatin-Based Chemotherapy.
Chen J; Luo X; Xie G; Chen K; Jiang H; Pan F; Li J; Ruan Z; Pang X; Liang H
Medicine (Baltimore); 2016 May; 95(19):e3652. PubMed ID: 27175691
[TBL] [Abstract][Full Text] [Related]
24. Polymorphisms in DNA repair genes, hair dye use, and the risk of non-Hodgkin lymphoma.
Guo H; Bassig BA; Lan Q; Zhu Y; Zhang Y; Holford TR; Leaderer B; Boyle P; Qin Q; Zhu C; Li N; Rothman N; Zheng T
Cancer Causes Control; 2014 Oct; 25(10):1261-70. PubMed ID: 25178586
[TBL] [Abstract][Full Text] [Related]
25. An association of selected ERCC2 and ERCC5 genes polymorphisms, the level of oxidative DNA damage and its repair efficiency with a risk of colorectal cancer in Polish population.
Kabzinski J; Przybylowska K; Dziki L; Dziki A; Majsterek I
Cancer Biomark; 2015; 15(4):413-23. PubMed ID: 25835182
[TBL] [Abstract][Full Text] [Related]
26. Association of DNA repair gene variants with colorectal cancer: risk, toxicity, and survival.
Salimzadeh H; Lindskog EB; Gustavsson B; Wettergren Y; Ljungman D
BMC Cancer; 2020 May; 20(1):409. PubMed ID: 32397974
[TBL] [Abstract][Full Text] [Related]
27. DNA repair gene XPC genotypes/haplotypes and risk of lung cancer in a Chinese population.
Hu Z; Wang Y; Wang X; Liang G; Miao X; Xu Y; Tan W; Wei Q; Lin D; Shen H
Int J Cancer; 2005 Jun; 115(3):478-83. PubMed ID: 15700316
[TBL] [Abstract][Full Text] [Related]
28. Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer.
Fleming ND; Agadjanian H; Nassanian H; Miller CW; Orsulic S; Karlan BY; Walsh CS
Cancer; 2012 Feb; 118(3):689-97. PubMed ID: 21751198
[TBL] [Abstract][Full Text] [Related]
29.
Liu ZQ; Chen GG; Sun RL; Chen C; Lu MY; Guan LF; Chi XL; Jian YQ; Zhu X; Liu RQ; Cai BY; Chen FF; Liu B
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30139812
[No Abstract] [Full Text] [Related]
30. Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case-control analysis.
Li C; Hu Z; Liu Z; Wang LE; Strom SS; Gershenwald JE; Lee JE; Ross MI; Mansfield PF; Cormier JN; Prieto VG; Duvic M; Grimm EA; Wei Q
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2526-32. PubMed ID: 17164380
[TBL] [Abstract][Full Text] [Related]
31. Effects of polymorphisms in the XRCC1, XRCC3, and XPG genes on clinical outcomes of platinum-based chemotherapy for treatment of non-small cell lung cancer.
Jin ZY; Zhao XT; Zhang LN; Wang Y; Yue WT; Xu SF
Genet Mol Res; 2014 Mar; 13(3):7617-25. PubMed ID: 24737519
[TBL] [Abstract][Full Text] [Related]
32. Associations of ABCB1 and XPC genetic polymorphisms with susceptibility to colorectal cancer and therapeutic prognosis in a Chinese population.
Yue AM; Xie ZB; Zhao HF; Guo SP; Shen YH; Wang HP
Asian Pac J Cancer Prev; 2013; 14(5):3085-91. PubMed ID: 23803084
[TBL] [Abstract][Full Text] [Related]
33. Study on bladder cancer susceptibility and genetic polymorphisms of XPC, XPG, and CYP in smokers and non-smokers.
Wen H; Feng CC; Fang ZJ; Xia GW; Jiang HW; Xu G; Huang XD; Ding Q
Actas Urol Esp; 2013 May; 37(5):259-65. PubMed ID: 23246108
[TBL] [Abstract][Full Text] [Related]
34. Association of the rs1346044 Polymorphism of the Werner Syndrome Gene RECQL2 with Increased Risk and Premature Onset of Breast Cancer.
Zins K; Frech B; Taubenschuss E; Schneeberger C; Abraham D; Schreiber M
Int J Mol Sci; 2015 Dec; 16(12):29643-53. PubMed ID: 26690424
[TBL] [Abstract][Full Text] [Related]
35. Laryngeal cancer risk associated with smoking and alcohol consumption is modified by genetic polymorphisms in ERCC5, ERCC6 and RAD23B but not by polymorphisms in five other nucleotide excision repair genes.
Abbasi R; Ramroth H; Becher H; Dietz A; Schmezer P; Popanda O
Int J Cancer; 2009 Sep; 125(6):1431-9. PubMed ID: 19444904
[TBL] [Abstract][Full Text] [Related]
36. An insight into clinical outcome of XPG polymorphisms in breast cancer.
Malik SS; Mubarik S; Masood N; Khadim MT
Mol Biol Rep; 2018 Dec; 45(6):2369-2375. PubMed ID: 30255276
[TBL] [Abstract][Full Text] [Related]
37. MTHFR Glu429Ala and ERCC5 His46His polymorphisms are associated with prognosis in colorectal cancer patients: analysis of two independent cohorts from Newfoundland.
Negandhi AA; Hyde A; Dicks E; Pollett W; Younghusband BH; Parfrey P; Green RC; Savas S
PLoS One; 2013; 8(4):e61469. PubMed ID: 23626689
[TBL] [Abstract][Full Text] [Related]
38. The ERCC1 C118T polymorphism predicts clinical outcomes of colorectal cancer patients receiving oxaliplatin-based chemotherapy: a meta-analysis based on 22 studies.
Qian YY; Liu XY; Wu Q; Song X; Chen XF; Liu YQ; Pei D; Shen LZ; Shu YQ
Asian Pac J Cancer Prev; 2014; 15(19):8383-90. PubMed ID: 25339033
[TBL] [Abstract][Full Text] [Related]
39. Acute myeloid leukemia outcome: role of nucleotide excision repair polymorphisms in intermediate risk patients.
Strom SS; Estey E; Outschoorn UM; Garcia-Manero G
Leuk Lymphoma; 2010 Apr; 51(4):598-605. PubMed ID: 20141440
[TBL] [Abstract][Full Text] [Related]
40. Nucleotide excision repair gene polymorphisms and risk of advanced colorectal adenoma: XPC polymorphisms modify smoking-related risk.
Huang WY; Berndt SI; Kang D; Chatterjee N; Chanock SJ; Yeager M; Welch R; Bresalier RS; Weissfeld JL; Hayes RB
Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):306-11. PubMed ID: 16492920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
